| Dr George Roy Pokorny, MD | |
|
113 Holland Ave, Albany, NY 12208-3410 | |
| (518) 626-5000 | |
| (518) 626-6558 |
| Full Name | Dr George Roy Pokorny |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 113 Holland Ave, Albany, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982677829 | NPI | - | NPPES |
| 003129932A | Medicaid | GA | |
| 0011829460001 | Medicaid | PA | |
| GA1426 | Other | GA | SC MEDICAID |
| 00965637 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 156399 (New York) | Primary |
| 207X00000X | Orthopaedic Surgery | 067744 (Georgia) | Secondary |
| Entity Name | Au Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841230620 PECOS PAC ID: 9931013513 Enrollment ID: O20040107000188 |
News Archive
AB Science SA, a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors, announces the publication of results from the human phase 2 study of masitinib carried-out in the treatment of progressive multiple sclerosis.
The World Health Organization (WHO) has granted prequalification to Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed])for active immunization of infants and children from 6 weeks through five years of age against invasive disease, pneumonia and otitis media caused by the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) contained in the vaccine.
An anesthetic regimen typically used during surgery on pregnant mothers appears to have a negative effect on the development of the fetus, according to a new study on mice conducted by neurobiologists from the National Center for Toxicological Research, in Arizona.
Tweaking a specific cell type's ability to absorb potassium in the brain improved walking and prolonged survival in a mouse model of Huntington's disease, reports a UCLA study published March 30 in the online edition of Nature Neuroscience. The discovery could point to new drug targets for treating the devastating disease, which strikes one in every 20,000 Americans.
Two different studies have shown that CRISPR - a gene editing tool, could be the next big thing in manipulating and modifying the DNA to suit the needs.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr George Roy Pokorny, MD Po Box 3011, Lebanon, PA 17042-3011 Ph: (518) 626-5000 | Dr George Roy Pokorny, MD 113 Holland Ave, Albany, NY 12208-3410 Ph: (518) 626-5000 |
News Archive
AB Science SA, a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors, announces the publication of results from the human phase 2 study of masitinib carried-out in the treatment of progressive multiple sclerosis.
The World Health Organization (WHO) has granted prequalification to Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed])for active immunization of infants and children from 6 weeks through five years of age against invasive disease, pneumonia and otitis media caused by the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) contained in the vaccine.
An anesthetic regimen typically used during surgery on pregnant mothers appears to have a negative effect on the development of the fetus, according to a new study on mice conducted by neurobiologists from the National Center for Toxicological Research, in Arizona.
Tweaking a specific cell type's ability to absorb potassium in the brain improved walking and prolonged survival in a mouse model of Huntington's disease, reports a UCLA study published March 30 in the online edition of Nature Neuroscience. The discovery could point to new drug targets for treating the devastating disease, which strikes one in every 20,000 Americans.
Two different studies have shown that CRISPR - a gene editing tool, could be the next big thing in manipulating and modifying the DNA to suit the needs.
› Verified 4 days ago
George S Zanaros, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1367 Washington Ave, Suite 200, Albany, NY 12206 Phone: 518-489-2666 Fax: 518-489-5933 | |
Kaushik Bagchi, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1367 Washington Ave, Suite 200, Albany, NY 12206 Phone: 518-489-2666 Fax: 518-489-2666 | |
Dr. Christopher De Camp, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 121 Everett Rd, Albany, NY 12205 Phone: 518-453-9088 Fax: 518-689-6111 | |
Dr. Justin Tyler Zaremba, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 43 New Scotland Ave, Albany, NY 12208 Phone: 518-453-3079 | |
Jeffrey Lozman, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1367 Washington Ave, Suite 200, Albany, NY 12206 Phone: 518-489-2666 Fax: 518-489-5933 | |
Dr. Imran Akhtar, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 121 Everett Rd, Albany, NY 12205 Phone: 518-489-2663 Fax: 518-689-3881 | |
Dr. Leonard E Goldstock, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 121 Everett Rd, Albany, NY 12205 Phone: 518-453-9088 Fax: 518-689-6111 |